RO5024048
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for RO5024048, covering 2016-08-01 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR) [Phase 2]